Fingerprint
Dive into the research topics of 'Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically